AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer

Clinical trial NCT07146919 · WITHDRAWN

Trial details

NCT number: NCT07146919
Sponsor: Centre Leon Berard
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Endometrial Carcinoma Ovarian Cancer Cervix Cancer

Start date: 2025-10-15
Primary completion: 2030-10-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.